If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tomoaki Inoue is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Oxidative Stress Medicine & Life Sciences
Protein Kinase C Medicine & Life Sciences
Diabetic Cardiomyopathies Medicine & Life Sciences
Lipase Medicine & Life Sciences
Bilirubin Medicine & Life Sciences
Insulin Medicine & Life Sciences
Insulin Resistance Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 250 Citations
  • 7 h-Index
  • 13 Article

Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines

Takei, R., Inoue, T., Sonoda, N., Kohjima, M., Okamoto, M., Sakamoto, R., Inoguchi, T. & Ogawa, Y., Jan 1 2019, In : PloS one. 14, 10, e0223302.

Research output: Contribution to journalArticle

Open Access
Abdominal Obesity
bilirubin
Bilirubin
insulin resistance
Insulin Resistance
2 Citations (Scopus)

Serum Bilirubin Concentration is Associated with Left Ventricular Remodeling in Patients with Type 2 Diabetes Mellitus: A Cohort Study

Inoue, T., Sonoda, N., Hiramatsu, S., Kimura, S., Ogawa, Y. & Inoguchi, T., Feb 1 2018, In : Diabetes Therapy. 9, 1, p. 331-338 8 p.

Research output: Contribution to journalArticle

Ventricular Remodeling
Bilirubin
Type 2 Diabetes Mellitus
Cohort Studies
Serum
40 Citations (Scopus)

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., Morise, A., Izumi, K., Ishizuka, N., Ohashi, Y., Noda, M., Kadowaki, T., Haneda, M., Iwashima, Y., Suda, T., Tamasawa, N. & 137 others, Daimon, M., Satoh, J., Takebe, N., Ishigaki, Y., Watanabe, T., Satoh, H., Kasai, K., Aso, Y., Ishibashi, S., Katayama, S., Ishikawa, S. E., Kakei, M., Namai, K., Hashimoto, N., Suzuki, Y., Onishi, S., Yokote, K., Matsuda, M., Masuzawa, M., Hayashi, Y., Saito, S., Ogihara, N., Ishihara, H., Tajima, N., Utsunomiya, K., Shimada, A., Itoh, H., Kawamori, R., Watada, H., Hayashi, M., Mori, Y., Shiba, T., Isogawa, A., Sakura, H., Odawara, M., Tobe, K., Tsukamoto, K., Yamauchi, T., Teramoto, T., Hirata, Y., Uchimura, I., Ogawa, Y., Yoshino, G., Hirose, T., Kajio, H., Atsumi, Y., Shimada, A., Oikawa, Y., Araki, A., Ueki, A., Ohno, A., Kitaoka, M., Fujita, Y., Moriya, T., Tojo, T., Shichiri, M., Suzuki, D., Toyoda, M., Hamano, K., Komi, R., Terauchi, Y., Kuzuya, N., Yamada, M., Takamura, T., Imura, M., Tanaka, H., Hayashi, M., Kato, Y., Itoh, M., Suzuki, A., Nakayama, M., Sano, T., Nakashima, E., Sumida, Y., Yano, Y., Tanaka, T., Murata, K., Kashiwagi, A., Maegawa, H., Kono, S., Inagaki, N., Kosugi, K., Yasuda, T., Yoshimasa, Y., Kishimoto, I., Sato, T., Hosoi, M., Yamasaki, T., Matsuhisa, M., Shimomura, I., Taniguchi, A., Kuroe, A., Kurose, T., Ohara, T., Sakaguchi, K., Namba, M., Kaku, K., Fujiwara, M., Shimizu, I., Ono, K., Ebisui, O., Tanizawa, Y., Okada, Y., Natori, S., Kodera, T., Sato, N., Ide, M., Yamada, K., Umeda, F., Natori, S., Eto, T., Mimura, K., Hiramatsu, S., Inoue, T., Takei, R., Ogo, A., Eguchi, K., Kawasaki, E., Koide, Y., Araki, E., Jinnouchi, H., Yamamoto, H., Motoyoshi, M., Hiyoshi, T., Tanaka, Y., Momoki, T., Sato, K., Yoneyama, A., Ito, K., Sobajima, H., Ikegami, H., Ikeda, M., Ikeda, H., Takahashi, K., Makino, H., Ueda, Y. & Nakazato, M., Dec 1 2017, In : The Lancet Diabetes and Endocrinology. 5, 12, p. 951-964 14 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Randomized Controlled Trials
Group Psychotherapy
Mortality
Blood Pressure
5 Citations (Scopus)
Hyperinsulinism
Left Ventricular Dysfunction
Type 2 Diabetes Mellitus
Blood Glucose
Insulin
40 Citations (Scopus)

GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats

Inoue, T., Inoguchi, T., Sonoda, N., Hendarto, H., Makimura, H., Sasaki, S., Yokomizo, H., Fujimura, Y., Miura, D. & Takayanagi, R., May 1 2015, In : Atherosclerosis. 240, 1, p. 250-259 10 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide 1
Streptozocin
Oxidative Stress
Apoptosis
AMP-Activated Protein Kinases